Skip Nav Destination
Article navigation
Editorial|
January 01 2006
Ethical Considerations in the Randomized Evaluation of Propofol Safety
Terrence F. Ackerman, PhD
Department of Human Values and Ethics, College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee
Address correspondence to: Terrence F. Ackerman, PhD, Department of Human Values and Ethics, College of Medicine, The University of Tennessee Health Science Center, 956 Court Avenue, Room B324, Memphis, TN 38163, email: [email protected]
Search for other works by this author on:
The Journal of Pediatric Pharmacology and Therapeutics (2006) 11 (1): 10–16.
Citation
Terrence F. Ackerman; Ethical Considerations in the Randomized Evaluation of Propofol Safety. The Journal of Pediatric Pharmacology and Therapeutics 1 January 2006; 11 (1): 10–16. doi: https://doi.org/10.5863/1551-6776-11.1.10
Download citation file:
Get Email Alerts
215
Views
Citing articles via
Creativity in Pediatric Clinical Pharmacology: Study Design and Oral Dosage Forms
Anne Zajicek, MD, PharmD
Retrospective Comparison of Early Versus Late Initiation of Long-Acting Insulin in Critically Ill Pediatric Patients in Diabetic Ketoacidosis
Emily S. Cormack, PharmD, Amber Howard, PharmD, Derrick Eddy, PharmD, Nick Schulte, PharmD
Atopic Dermatitis: A Review of Diagnosis and Treatment
Jack Jeskey, DO, Christine Kurien, DO, Henry Blunk, DO, Kiran Sehmi, MD, Sathya Areti, MD, Delena Nguyen, MD, Robert Hostoffer, DO
Pediatric Prescribers’ Knowledge of the Ew Meds™ List and Taste Masking
Dafne Espinal Peña, BS, Jill A. Morgan, PharmD, Amy Kruger Howard, MS, PharmD
Optimal Dosing Recommendations of Clonidine in Pediatrics Using Physiologically Based Pharmacokinetic Modeling
Venkata Yellepeddi, PhD, Sharlo Bayless, MD, Madison Parrot, BS, Catherine M. Sherwin, PhD